43.33 USD
-0.28 (-0.64%)
Taking everything into account, EXEL scores 8 out of 10 in our fundamental rating. EXEL was compared to 525 industry peers in the Biotechnology industry. Both the health and profitability get an excellent rating, making EXEL a very profitable company, without any liquidiy or solvency issues. An interesting combination arises when we look at growth and value: EXEL is growing strongly while it also seems undervalued. These ratings could make EXEL a good candidate for value and growth and quality investing.
1. Profitability
1.1 Basic Checks
- In the past year EXEL was profitable.
- EXEL had a positive operating cash flow in the past year.
- In the past 5 years EXEL has always been profitable.
- Each year in the past 5 years EXEL had a positive operating cash flow.
1.2 Ratios
- EXEL has a Return On Assets of 24.01%. This is amongst the best in the industry. EXEL outperforms 97.52% of its industry peers.
- EXEL has a better Return On Equity (31.37%) than 97.71% of its industry peers.
- With an excellent Return On Invested Capital value of 26.31%, EXEL belongs to the best of the industry, outperforming 98.86% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for EXEL is significantly below the industry average of 18.07%.
- The 3 year average ROIC (10.78%) for EXEL is below the current ROIC(26.31%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.01% | ||
| ROE | 31.37% | ||
| ROIC | 26.31% |
ROA(3y)10.23%
ROA(5y)8.95%
ROE(3y)13.24%
ROE(5y)11.23%
ROIC(3y)10.78%
ROIC(5y)9.34%
1.3 Margins
- With an excellent Profit Margin value of 29.63%, EXEL belongs to the best of the industry, outperforming 95.81% of the companies in the same industry.
- EXEL's Profit Margin has declined in the last couple of years.
- With an excellent Operating Margin value of 35.85%, EXEL belongs to the best of the industry, outperforming 97.71% of the companies in the same industry.
- In the last couple of years the Operating Margin of EXEL has declined.
- With an excellent Gross Margin value of 96.63%, EXEL belongs to the best of the industry, outperforming 96.57% of the companies in the same industry.
- EXEL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 35.85% | ||
| PM (TTM) | 29.63% | ||
| GM | 96.63% |
OM growth 3Y16.77%
OM growth 5Y-3.58%
PM growth 3Y14.28%
PM growth 5Y-6.24%
GM growth 3Y0.06%
GM growth 5Y-0.02%
2. Health
2.1 Basic Checks
- EXEL has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- EXEL has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, EXEL has less shares outstanding
- There is no outstanding debt for EXEL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 12.74 indicates that EXEL is not in any danger for bankruptcy at the moment.
- With an excellent Altman-Z score value of 12.74, EXEL belongs to the best of the industry, outperforming 84.57% of the companies in the same industry.
- There is no outstanding debt for EXEL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 12.74 |
ROIC/WACC2.96
WACC8.88%
2.3 Liquidity
- EXEL has a Current Ratio of 3.75. This indicates that EXEL is financially healthy and has no problem in meeting its short term obligations.
- With a Current ratio value of 3.75, EXEL perfoms like the industry average, outperforming 45.33% of the companies in the same industry.
- EXEL has a Quick Ratio of 3.68. This indicates that EXEL is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 3.68, EXEL is in line with its industry, outperforming 46.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.75 | ||
| Quick Ratio | 3.68 |
3. Growth
3.1 Past
- EXEL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.51%, which is quite impressive.
- The Earnings Per Share has been growing by 12.65% on average over the past years. This is quite good.
- The Revenue has grown by 9.93% in the past year. This is quite good.
- EXEL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.51% yearly.
EPS 1Y (TTM)44.51%
EPS 3Y37.61%
EPS 5Y12.65%
EPS Q2Q%72.5%
Revenue 1Y (TTM)9.93%
Revenue growth 3Y14.76%
Revenue growth 5Y17.51%
Sales Q2Q%10.79%
3.2 Future
- Based on estimates for the next years, EXEL will show a very strong growth in Earnings Per Share. The EPS will grow by 25.68% on average per year.
- Based on estimates for the next years, EXEL will show a quite strong growth in Revenue. The Revenue will grow by 9.99% on average per year.
EPS Next Y46.91%
EPS Next 2Y32.4%
EPS Next 3Y30.29%
EPS Next 5Y25.68%
Revenue Next Year7.7%
Revenue Next 2Y9.84%
Revenue Next 3Y11.53%
Revenue Next 5Y9.99%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 18.28 indicates a rather expensive valuation of EXEL.
- Based on the Price/Earnings ratio, EXEL is valued cheaply inside the industry as 95.05% of the companies are valued more expensively.
- EXEL is valuated rather cheaply when we compare the Price/Earnings ratio to 27.25, which is the current average of the S&P500 Index.
- EXEL is valuated correctly with a Price/Forward Earnings ratio of 13.36.
- 96.57% of the companies in the same industry are more expensive than EXEL, based on the Price/Forward Earnings ratio.
- EXEL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.98.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.28 | ||
| Fwd PE | 13.36 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, EXEL is valued cheaply inside the industry as 96.38% of the companies are valued more expensively.
- EXEL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. EXEL is cheaper than 96.76% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.9 | ||
| EV/EBITDA | 11.87 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- EXEL has an outstanding profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as EXEL's earnings are expected to grow with 30.29% in the coming years.
PEG (NY)0.39
PEG (5Y)1.45
EPS Next 2Y32.4%
EPS Next 3Y30.29%
5. Dividend
5.1 Amount
- EXEL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
EXELIXIS INC / EXEL FAQ
What is the fundamental rating for EXEL stock?
ChartMill assigns a fundamental rating of 8 / 10 to EXEL.
Can you provide the valuation status for EXELIXIS INC?
ChartMill assigns a valuation rating of 8 / 10 to EXELIXIS INC (EXEL). This can be considered as Undervalued.
Can you provide the profitability details for EXELIXIS INC?
EXELIXIS INC (EXEL) has a profitability rating of 8 / 10.
Can you provide the financial health for EXEL stock?
The financial health rating of EXELIXIS INC (EXEL) is 9 / 10.
What is the expected EPS growth for EXELIXIS INC (EXEL) stock?
The Earnings per Share (EPS) of EXELIXIS INC (EXEL) is expected to grow by 46.91% in the next year.